The present study demonstrates that Galectin-1 induces sorafenib resistance in HCC cells through MET and AXL signaling and reveals a new link between Galectin-1 signaling and sorafenib-mediated ferroptosis. The gene discussed is MET; the disease is hepatocellular carcinoma.